Viewing Study NCT02862106


Ignite Creation Date: 2025-12-26 @ 3:59 PM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT02862106
Status: COMPLETED
Last Update Posted: 2019-08-20
First Post: 2016-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
Sponsor: Chongqing Jiachen Biotechnology Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Hepatitis B View
None HBeAg positive View
None Therapeutic HBV Vaccine View
None HBV-specific Cytotoxic T Lymphocyte View